Press Releases

Oct 3, 2017

Summary Toggle Structural Variation Detection a Key Focus of PacBio Sequencing Projects Presented at ASHG Annual Meeting

More than 30 presentations demonstrate utility of SMRT Sequencing for human biomedical applications

Structural Variation Detection a Key Focus of PacBio Sequencing Projects Presented at ASHG Annual Meeting 31.3 KB
Aug 2, 2017

Summary Toggle Pacific Biosciences of California, Inc. Announces Second Quarter 2017 Financial Results

Product and Service Revenue Increases by 17% Over Same Period in Previous Year

Pacific Biosciences of California, Inc. Announces Second Quarter 2017 Financial Results 24.1 KB
Aug 2, 2017

Summary Toggle PacBio Announces New Agreement with Novogene to Purchase Ten Sequel Systems

Increases Novogene's Capacity to Run 20 Sequel Systems at a Time

PacBio Announces New Agreement with Novogene to Purchase Ten Sequel Systems 24.1 KB
Jul 24, 2017

Summary Toggle Pacific Biosciences of California, Inc. Second Quarter 2017 Financial Results Call

MENLO PARK, Calif. , July 24, 2017 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ:PACB) will hold its quarterly conference call to discuss its Second Quarter 2017 Financial Results on Wednesday, August 2, 2017 , at 4:30pm Eastern Time .

Pacific Biosciences of California, Inc. Second Quarter 2017 Financial Results Call 18.7 KB
Jul 18, 2017

Summary Toggle Novogene and Pacific Biosciences to Jointly Develop and Co-Market Novel Applications Based on Sequel Platform

SAN DIEGO and MENLO PARK, Calif. , July 18, 2017 (GLOBE NEWSWIRE) -- Novogene, a leading global provider of genomic services and solutions, and Pacific Biosciences of California, Inc. (NASDAQ:PACB), the leader in long-read sequencing, have agreed to jointly develop and promote novel applications

Novogene and Pacific Biosciences to Jointly Develop and Co-Market Novel Applications Based on Sequel Platform 24.8 KB
Jun 22, 2017

Summary Toggle PacBio Technology Resolves Complex Maize Genome, Driving Demand for Other Large-Scale AgBio Sequencing Projects

SMRT Sequencing Offers Significant Improvements for Reference Genomes at Much Lower Cost

PacBio Technology Resolves Complex Maize Genome, Driving Demand for Other Large-Scale AgBio Sequencing Projects 25.3 KB
Jun 15, 2017

Summary Toggle Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock

MENLO PARK, Calif. , June 15, 2017 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ:PACB) (the "Company") today announced that it has priced its previously announced underwritten public offering of 15,419,354 shares of its common stock at a price to the public of $3.10 per

Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock 19.3 KB
Jun 14, 2017

Summary Toggle Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock

MENLO PARK, Calif. , June 14, 2017 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Pacific Biosciences also intends to grant the underwriters a 30-day option

Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock 19.3 KB
May 22, 2017

Summary Toggle Recent Publications Demonstrate Rapid Adoption of SMRT Sequencing for Plant and Animal Transcriptome Analysis

Long Reads Reveal Important Genes and Splicing Complexity Missed by Short-Read Sequencers

Recent Publications Demonstrate Rapid Adoption of SMRT Sequencing for Plant and Animal Transcriptome Analysis 28 KB
Apr 26, 2017

Summary Toggle Pacific Biosciences of California, Inc. Announces First Quarter 2017 Financial Results

Product and Service Revenue Increases by 60% Over Same Period in Previous Year

Pacific Biosciences of California, Inc. Announces First Quarter 2017 Financial Results 27.8 KB

STOCK QUOTE

:
Price
Last Trade
Change
Change (%)
Volume
52 Week High
52 Week Low
Day High
Day Low

Investor
Contact

Pacific Biosciences

1305 O’Brien Drive

Menlo Park, CA 94025